Biocon Biologics’ partner receives positive EU CHMP opinion for biosimilar human insulin for IV…
Celerity Pharma uses Biocon Biologics’ insulin drug substance to develop the product
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.